Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
09 04 2020
Historique:
pubmed: 7 3 2020
medline: 8 10 2020
entrez: 6 3 2020
Statut: ppublish

Résumé

Semisynthetic artemisinins and other bioactive peroxides are best known for their powerful antimalarial activities, and they also show substantial activity against schistosomes-another hemoglobin-degrading pathogen. Building on this discovery, we now describe the initial structure-activity relationship (SAR) of antischistosomal ozonide carboxylic acids OZ418 (

Identifiants

pubmed: 32134263
doi: 10.1021/acs.jmedchem.0c00069
pmc: PMC7182039
mid: NIHMS1579713
doi:

Substances chimiques

Carboxylic Acids 0
Heterocyclic Compounds, 1-Ring 0
Schistosomicides 0
Spiro Compounds 0
Adamantane PJY633525U

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3723-3736

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI116723
Pays : United States

Références

Bioorg Med Chem Lett. 2005 Nov 15;15(22):4910-4
pubmed: 16169218
Curr Pharm Des. 2012;18(24):3531-8
pubmed: 22607145
Parasitol Res. 2014 Sep;113(9):3259-66
pubmed: 24948106
J Med Chem. 2017 Apr 13;60(7):2654-2668
pubmed: 28052200
PLoS Negl Trop Dis. 2012;6(2):e1474
pubmed: 22348155
ACS Infect Dis. 2016 Jan 8;2(1):54-61
pubmed: 26819968
Anal Chem. 2000 Apr 15;72(8):1781-7
pubmed: 10784141
Science. 1985 May 31;228(4703):1049-55
pubmed: 3887571
J Pharm Sci. 2003 Nov;92(11):2236-48
pubmed: 14603509
Curr Opin Microbiol. 2013 Dec;16(6):722-7
pubmed: 23932203
J Med Chem. 2011 Aug 11;54(15):5540-61
pubmed: 21696174
Antimicrob Agents Chemother. 2007 Aug;51(8):2991-3
pubmed: 17562801
ACS Infect Dis. 2019 Dec 13;5(12):2076-2086
pubmed: 31622078
Parasitol Res. 2014 May;113(5):1769-73
pubmed: 24609234
Acc Chem Res. 2010 Nov 16;43(11):1444-51
pubmed: 20804120
Angew Chem Int Ed Engl. 2017 Jan 19;56(4):1152-1157
pubmed: 28000334
ACS Omega. 2018 Sep 30;3(9):11362-11367
pubmed: 30288462
Nat Commun. 2015 Dec 22;6:10111
pubmed: 26694030
Bioorg Med Chem. 2006 Sep 15;14(18):6368-82
pubmed: 16759871
J Med Chem. 2005 Jul 28;48(15):4953-61
pubmed: 16033274
Parasitol Int. 2018 Apr;67(2):107-111
pubmed: 29081387
Pharmacol Res. 2016 Aug;110:216-226
pubmed: 26902577
Pharm Res. 1997 May;14(5):568-71
pubmed: 9165525
Antimicrob Agents Chemother. 2007 Apr;51(4):1440-5
pubmed: 17283188
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4400-5
pubmed: 21300861
Nat Protoc. 2019 Feb;14(2):461-481
pubmed: 30610241
Angew Chem Int Ed Engl. 2013 Jul 29;52(31):7936-56
pubmed: 23813602
J Med Chem. 2001 Jul 19;44(15):2490-7
pubmed: 11448232
ACS Infect Dis. 2019 Dec 13;5(12):2067-2075
pubmed: 31626733
Nat Med. 2011 Oct 11;17(10):1217-20
pubmed: 21989013
Antimicrob Agents Chemother. 2012 Feb;56(2):1090-2
pubmed: 22106214
Int J Parasitol. 2002 Dec 4;32(13):1655-60
pubmed: 12435450
Angew Chem Int Ed Engl. 2016 May 23;55(22):6401-5
pubmed: 27089538
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7364-7371
pubmed: 27697760
J Org Chem. 2004 Sep 17;69(19):6470-3
pubmed: 15357611
Bioorg Med Chem Lett. 2010 Apr 15;20(8):2481-4
pubmed: 20303754
Infect Dis Poverty. 2017 Mar 28;6(1):74
pubmed: 28351414
Nat Rev Microbiol. 2009 Dec;7(12):864-74
pubmed: 19881520
Antimicrob Agents Chemother. 2008 Apr;52(4):1291-6
pubmed: 18268087

Auteurs

Jianbo Wu (J)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Xiaofang Wang (X)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Francis C K Chiu (FCK)

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

Cécile Häberli (C)

Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland.
University of Basel, CH-4003 Basel, Switzerland.

David M Shackleford (DM)

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

Eileen Ryan (E)

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

Sriraghavan Kamaraj (S)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Vivek J Bulbule (VJ)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Alexander I Wallick (AI)

Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.

Yuxiang Dong (Y)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Karen L White (KL)

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

Paul H Davis (PH)

Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska 68182, United States.

Susan A Charman (SA)

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), 381 Royal Parade, Parkville, Victoria 3052, Australia.

Jennifer Keiser (J)

Swiss Tropical and Public Health Institute, Socinstrasse 57, CH-4002 Basel, Switzerland.
University of Basel, CH-4003 Basel, Switzerland.

Jonathan L Vennerstrom (JL)

College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH